- Conditions
- CLL, DLBCL, FL, +3 more
- Locations
-
- Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
Clinical trial condition
MZL
Explore clinical trials studying MZL. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
MZL trial results
NCT06510309
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
Not Yet Recruiting
CD20 Monoclonal Antibody-Based First-Line Therapy in Treatment-Naive Marginal Zone B-Cell Lymphoma
NCT07492407
- Conditions
- MZL
- Locations
-
Not specified
Not Yet Recruiting
Efficacy and Safety of Lisaftoclax (APG-2575) Monotherapy in Patients With Indolent Lymphoma
NCT07459608
- Conditions
- CLL / SLL, Indolent Lymphoma, MZL, +1 more
- Locations
-
- Henan cancer hospital Zhengzhou, Henan, China
NCT03846427
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +10 more
- Locations
-
- Clinical Research Alliance, Inc Westbury, New York, United States
- The Charlotte Mecklenburg Hospital Authority Charlotte, North Carolina, United States
- Canberra Hospital Garran, Australian Capital Territory, Australia
- Concord Repatriation General Hospital Concord, New South Wales, Australia
NCT03797456
- Conditions
- MZL
- Locations
-
- Anhui Provincial Hospital Hefei, Anhui, China
- Anhui Cancer Hospital Hefei, Anhui, China
- Chinese People's Liberation Army General Hospital Fifth Medical Center Beijing, Beijing Municipality, China
- Peking university People's Hospital Beijing, Beijing Municipality, China